Results 71 to 80 of about 3,656,183 (130)
The heart in inherited metabolic disorders: lysosomal and glycogen storage diseases
Lysosomal storage diseases (LSDs) represent a large and heterogeneous group of rare inherited disorders caused by a defective function of one of the lysosomal acid hydrolases, their activator proteins, or proteins necessary for intracellular trafficking.
Ales Linhart
core +1 more source
Common and uncommon pathogenic cascades in lysosomal storage diseases.
Lysosomal storage diseases (LSDs), of which about 50 are known, are caused by the defective activity of lysosomal proteins, resulting in accumulation of unmetabolized substrates. As a result, a variety of pathogenic cascades are activated such as altered
core +1 more source
Lysosomal diseases: Overview on current diagnosis and treatment
Lysosomal diseases (LDs), also known as lysosomal storage diseases (LSDs), are a heterogeneous group of conditions caused by defects in lysosomal function.
Fabiano de Oliveira Poswar +8 more
doaj +1 more source
Perinatal Gene Transfer to the Liver [PDF]
The liver acts as a host to many functions hence raising the possibility that any one may be compromised by a single gene defect. Inherited or de novo mutations in these genes may result in relatively mild diseases or be so devastating that death within
Buckley, SM +20 more
core +1 more source
Haematopoietic development and immunological function in the absence of cathepsin D [PDF]
Background: Cathepsin D is a well-characterized aspartic protease expressed ubiquitously in lysosomes. Cathepsin D deficiency is associated with a spectrum of pathologies leading ultimately to death.
Calogero Tulone +17 more
core +1 more source
Lysosomal Ca(2+) homeostasis: role in pathogenesis of lysosomal storage diseases.
Disrupted cellular Ca(2+) signaling is believed to play a role in a number of human diseases including lysosomal storage diseases (LSD). LSDs are a group of ∼50 diseases caused predominantly by mutations in lysosomal proteins that result in accumulation ...
Platt, Frances M. +3 more
core +1 more source
Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis.
Paediatric neurodegenerative diseases are frequently caused by inborn errors in glycosphingolipid (GSL) catabolism and are collectively termed the glycosphingolipidoses.
M. Jeyakumar +3 more
core +1 more source
Lysosomal storage diseases in non-immune hydrops fetalis pregnancies.
Contains fulltext : 50653.pdf (Publisher’s version ) (Open Access)BACKGROUND: At least 20 inborn errors of metabolism may cause hydrops fetalis. Most of these are lysosomal storage diseases. The study proposes a diagnostic flowchart for
Pim M.W. Janssens +29 more
core +1 more source
The lysosomal storage disease alpha-mannosidosis (AMD) is caused by a genetic deficiency of lysosomal alpha-mannosidase, leading to the widespread presence of storage lesions in the brain and other tissues.
Jacqueline E. Hunter +6 more
doaj +1 more source
The emerging role and clinicopathological significance of MFSD12 in cancer and lysosomal storage diseases [PDF]
MFSD12 protein has recently risen as a key factor in malignancy and plays a potential role in a variety of complex oncogenic signaling cascades. Current studies suggest that MFSD12 has a positive complex role in the growth and progression of tumors such ...
Liqiong Ding
core +1 more source

